Walgreens EBIT 2010-2024 | WBA

Walgreens annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Walgreens EBIT for the quarter ending August 31, 2024 was $-0.929B, a 142.56% increase year-over-year.
  • Walgreens EBIT for the twelve months ending August 31, 2024 was $-13.864B, a 109.14% increase year-over-year.
  • Walgreens 2024 annual EBIT was $-13.864B, a 109.14% increase from 2023.
  • Walgreens 2023 annual EBIT was $-6.629B, a 466.85% decline from 2022.
  • Walgreens 2022 annual EBIT was $1.807B, a 50.21% increase from 2021.
Walgreens Annual EBIT
(Millions of US $)
2024 $-13,864
2023 $-6,629
2022 $1,807
2021 $1,203
2020 $1,323
2019 $4,930
2018 $6,480
2017 $5,619
2016 $6,038
2015 $4,983
2014 $4,811
2013 $4,588
2012 $3,464
2011 $4,365
2010 $3,458
2009 $3,247
Walgreens Quarterly EBIT
(Millions of US $)
2024-08-31 $-929
2024-05-31 $154
2024-02-29 $-13,092
2023-11-30 $3
2023-08-31 $-383
2023-05-31 $-418
2023-02-28 $271
2022-11-30 $-6,099
2022-08-31 $-734
2022-05-31 $-193
2022-02-28 $1,350
2021-11-30 $1,384
2021-08-31 $968
2021-05-31 $1,231
2021-02-28 $912
2020-11-30 $-1,908
2020-08-31 $572
2020-05-31 $-1,440
2020-02-29 $1,165
2019-11-30 $1,026
2019-08-31 $704
2019-05-31 $1,186
2019-02-28 $1,601
2018-11-30 $1,439
2018-08-31 $1,445
2018-05-31 $1,649
2018-02-28 $2,179
2017-11-30 $1,207
2017-08-31 $1,033
2017-05-31 $1,601
2017-02-28 $1,521
2016-11-30 $1,464
2016-08-31 $1,174
2016-05-31 $1,536
2016-02-29 $1,860
2015-11-30 $1,468
2015-08-31 $836
2015-05-31 $1,401
2015-02-28 $1,478
2014-11-30 $1,268
2014-08-31 $1,224
2014-05-31 $1,159
2014-02-28 $1,353
2013-11-30 $1,075
2013-08-31 $1,457
2013-05-31 $1,122
2013-02-28 $1,300
2012-11-30 $709
2012-08-31 $586
2012-05-31 $873
2012-02-29 $1,105
2011-11-30 $900
2011-08-31 $1,266
2011-05-31 $951
2011-02-28 $1,207
2010-11-30 $941
2010-08-31 $746
2010-05-31 $829
2010-02-28 $1,086
2009-11-30 $797
2009-08-31 $702
2009-05-31 $846
2009-02-28 $1,030
Sector Industry Market Cap Revenue
Retail/Wholesale Retail - Drug Stores $7.168B $147.658B
Walgreens Boots Alliance, Inc. operates as a retail drugstore chain. The Company sells prescription and non-prescription drugs, as well as general merchandise products, including household items, convenience and fresh foods, personal care, beauty care, photofinishing and candy. Its pharmacy, health and wellness services include retail, specialty, infusion and respiratory services, mail service and convenient care clinics. The Company offers its products and services through drugstores, as well as through mail, by telephone and online. Walgreens Boots Alliance, Inc., is based in Deerfield, Illinois.
Stock Name Country Market Cap PE Ratio
CVS Health (CVS) United States $70.181B 8.78
Herbalife (HLF) Cayman Islands $0.778B 4.11
China Jo-Jo Drugstores Holdings (CJJD) China $0.014B 0.00
GNC Holdings (GNC) United States $0.000B 0.00